Published in Mol Psychiatry on January 01, 2006
Maternal immune activation alters fetal brain development through interleukin-6. J Neurosci (2007) 4.06
Elevated maternal C-reactive protein and increased risk of schizophrenia in a national birth cohort. Am J Psychiatry (2014) 2.91
Molecular evidence for increased expression of genes related to immune and chaperone function in the prefrontal cortex in schizophrenia. Biol Psychiatry (2007) 2.12
Prenatal interaction of mutant DISC1 and immune activation produces adult psychopathology. Biol Psychiatry (2010) 2.11
Schizophrenia and autism: both shared and disorder-specific pathogenesis via perinatal inflammation? Pediatr Res (2011) 1.62
Increased midgestational IFN-γ, IL-4 and IL-5 in women bearing a child with autism: A case-control study. Mol Autism (2011) 1.51
A review of the fetal brain cytokine imbalance hypothesis of schizophrenia. Schizophr Bull (2008) 1.49
Prenatal stress: role in psychotic and depressive diseases. Psychopharmacology (Berl) (2010) 1.29
Genetic associations with schizophrenia: meta-analyses of 12 candidate genes. Schizophr Res (2008) 1.29
Is maternal influenza or fever during pregnancy associated with autism or developmental delays? Results from the CHARGE (CHildhood Autism Risks from Genetics and Environment) study. J Autism Dev Disord (2013) 1.25
Prenatal activation of microglia induces delayed impairment of glutamatergic synaptic function. PLoS One (2008) 1.13
Inflammatory cytokines and neurological and neurocognitive alterations in the course of schizophrenia. Biol Psychiatry (2013) 1.06
Prenatal and perinatal risk factors for autism in China. J Autism Dev Disord (2010) 1.04
Reduced ventricular proliferation in the foetal cortex following maternal inflammation in the mouse. Brain (2011) 1.03
Prenatal and postnatal maternal contributions in the infection model of schizophrenia. Exp Brain Res (2006) 1.03
Maternal immune activation by LPS selectively alters specific gene expression profiles of interneuron migration and oxidative stress in the fetus without triggering a fetal immune response. Brain Behav Immun (2012) 1.01
Prenatal exposure to infection: a primary mechanism for abnormal dopaminergic development in schizophrenia. Psychopharmacology (Berl) (2009) 1.01
Maternal Infection During Pregnancy and Autism Spectrum Disorders. J Autism Dev Disord (2015) 1.00
The consequences of chorioamnionitis: preterm birth and effects on development. J Pregnancy (2013) 0.99
The Long and the Short of it: Gene and Environment Interactions During Early Cortical Development and Consequences for Long-Term Neurological Disease. Front Psychiatry (2012) 0.97
Postnatal administration of IL-1Ra exerts neuroprotective effects following perinatal inflammation and/or hypoxic-ischemic injuries. Brain Behav Immun (2012) 0.96
Maternal immune activation and autism spectrum disorder: interleukin-6 signaling as a key mechanistic pathway. Neurosignals (2010) 0.94
Diabetes mellitus during pregnancy and increased risk of schizophrenia in offspring: a review of the evidence and putative mechanisms. J Psychiatry Neurosci (2008) 0.93
Association of maternal exposure to childhood abuse with elevated risk for autism in offspring. JAMA Psychiatry (2013) 0.93
Cutaneous tactile allodynia associated with microvascular dysfunction in muscle. Mol Pain (2008) 0.93
Attenuated fever in rats during late pregnancy is linked to suppressed interleukin-6 production after localized inflammation with turpentine. J Physiol (2007) 0.92
Prenatal stress induces schizophrenia-like alterations of serotonin 2A and metabotropic glutamate 2 receptors in the adult offspring: role of maternal immune system. J Neurosci (2013) 0.92
Placental TNF-α signaling in illness-induced complications of pregnancy. Am J Pathol (2011) 0.90
Prenatal inflammation-induced hypoferremia alters dopamine function in the adult offspring in rat: relevance for schizophrenia. PLoS One (2010) 0.90
Mouse model of intrauterine inflammation: sex-specific differences in long-term neurologic and immune sequelae. Brain Behav Immun (2014) 0.88
Prenatal activation of Toll-like receptors-3 by administration of the viral mimetic poly(I:C) changes synaptic proteins, N-methyl-D-aspartate receptors and neurogenesis markers in offspring. Mol Brain (2012) 0.88
Individual differences in maternal response to immune challenge predict offspring behavior: contribution of environmental factors. Behav Brain Res (2011) 0.88
Models of neurodevelopmental abnormalities in schizophrenia. Curr Top Behav Neurosci (2010) 0.88
Brain enlargement and increased behavioral and cytokine reactivity in infant monkeys following acute prenatal endotoxemia. Behav Brain Res (2010) 0.86
Sex effects on neurodevelopmental outcomes of innate immune activation during prenatal and neonatal life. Horm Behav (2012) 0.86
Immune stress in late pregnant rats decreases length of gestation and fecundity, and alters later cognitive and affective behaviour of surviving pre-adolescent offspring. Stress (2011) 0.84
LPS exposure increases maternal corticosterone levels, causes placental injury and increases IL-1Β levels in adult rat offspring: relevance to autism. PLoS One (2013) 0.84
Alkaline phosphatase protects lipopolysaccharide-induced early pregnancy defects in mice. PLoS One (2015) 0.83
Early effects of lipopolysaccharide-induced inflammation on foetal brain development in rat. ASN Neuro (2011) 0.83
Autism with intellectual disability is associated with increased levels of maternal cytokines and chemokines during gestation. Mol Psychiatry (2016) 0.82
Maternal immune activation evoked by polyinosinic:polycytidylic acid does not evoke microglial cell activation in the embryo. Front Cell Neurosci (2015) 0.82
Interleukin-6 (IL-6) receptor/IL-6 fusion protein (Hyper IL-6) effects on the neonatal mouse brain: possible role for IL-6 trans-signaling in brain development and functional neurobehavioral outcomes. Brain Behav Immun (2012) 0.82
Deficient maternal care resulting from immunological stress during pregnancy is associated with a sex-dependent enhancement of conditioned fear in the offspring. J Neurodev Disord (2008) 0.82
Cytokines and the neurodevelopmental basis of mental illness. Front Neurosci (2013) 0.81
Prenatal LPS increases inflammation in the substantia nigra of Gdnf heterozygous mice. Brain Pathol (2010) 0.81
Profile of minocycline and its potential in the treatment of schizophrenia. Neuropsychiatr Dis Treat (2014) 0.79
Gender-dependent effects of maternal immune activation on the behavior of mouse offspring. PLoS One (2014) 0.79
Prenatal immune challenge in rats: effects of polyinosinic-polycytidylic acid on spatial learning, prepulse inhibition, conditioned fear, and responses to MK-801 and amphetamine. Neurotoxicol Teratol (2014) 0.79
Prenatal immune programming of the sex-dependent risk for major depression. Transl Psychiatry (2016) 0.79
Nicotine ameliorates schizophrenia-like cognitive deficits induced by maternal LPS exposure: a study in rats. Dis Model Mech (2016) 0.79
Hypo-anxious phenotype of adolescent offspring prenatally exposed to LPS is associated with reduced mGluR5 expression in hippocampus. Open J Med Psychol (2014) 0.78
Neuroinflammation in Autism: Plausible Role of Maternal Inflammation, Dietary Omega 3, and Microbiota. Neural Plast (2016) 0.77
Toll-like receptor 4-mediated immune stress in pregnant rats activates STAT3 in the fetal brain: role of interleukin-6. Pediatr Res (2015) 0.77
Allergic fetal priming leads to developmental, behavioral and neurobiological changes in mice. Transl Psychiatry (2015) 0.77
Neuroimmunological aberrations and cerebral asymmetry abnormalities in schizophrenia: select perspectives on pathogenesis. Clin Psychopharmacol Neurosci (2014) 0.77
The Impact of Maternal High-Fat Diet Consumption on Neural Development and Behavior of Offspring. Int J Obes Suppl (2015) 0.77
Matrix metalloproteinases in autism spectrum disorders. J Mol Psychiatry (2013) 0.76
Placental-mediated increased cytokine response to lipopolysaccharides: a potential mechanism for enhanced inflammation susceptibility of the preterm fetus. J Inflamm Res (2012) 0.76
Behavioral alterations in rat offspring following maternal immune activation and ELR-CXC chemokine receptor antagonism during pregnancy: implications for neurodevelopmental psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry (2014) 0.76
Brain in flames - animal models of psychosis: utility and limitations. Neuropsychiatr Dis Treat (2015) 0.76
Epigenetic signaling in schizophrenia. Cell Signal (2015) 0.76
Prevention of behavioral deficits in rats exposed to folate receptor antibodies: implication in autism. Mol Psychiatry (2016) 0.76
An animal model for chorioamnionitis at term. Am J Obstet Gynecol (2015) 0.75
Cognitive mapping deficits in schizophrenia: a critical overview. Indian J Psychol Med (2014) 0.75
Contribution of nonprimate animal models in understanding the etiology of schizophrenia. J Psychiatry Neurosci (2011) 0.75
Tumor necrosis factor-α and -β genetic polymorphisms as a risk factor in Saudi patients with schizophrenia. Neuropsychiatr Dis Treat (2017) 0.75
The Local and Systemic Immune Response to Intrauterine LPS in the Prepartum Mouse. Biol Reprod (2016) 0.75
Tumour necrosis factor-mediated homeostatic synaptic plasticity in behavioural models: testing a role in maternal immune activation. Philos Trans R Soc Lond B Biol Sci (2017) 0.75
Perinatal Arterial Ischemic Stroke Is Associated to Materno-Fetal Immune Activation and Intracranial Arteritis. Int J Mol Sci (2016) 0.75
Changes in Astroglial Markers in a Maternal Immune Activation Model of Schizophrenia in Wistar Rats are Dependent on Sex. Front Cell Neurosci (2015) 0.75
Animal Models of Maternal Immune Activation in Depression Research. Curr Neuropharmacol (2016) 0.75
Prenatal Activation of Toll-Like Receptor-4 Dampens Adult Hippocampal Neurogenesis in An IL-6 Dependent Manner. Front Cell Neurosci (2016) 0.75
Positive modulation of α5 GABAA receptors in preadolescence prevents reduced locomotor response to amphetamine in adult female but not male rats prenatally exposed to lipopolysaccharide. Int J Dev Neurosci (2017) 0.75
Maternal Exposure to Childhood Abuse is Associated with Mate Selection: Implications for Autism in Offspring. J Autism Dev Disord (2017) 0.75
FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis. Science (1998) 5.29
Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature (2001) 4.82
Effects of a decision support system on the diagnostic accuracy of users: a preliminary report. J Am Med Inform Assoc (1997) 4.61
Two distinct mechanisms for long-range patterning by Decapentaplegic in the Drosophila wing. Nature (1996) 3.81
Requirement for Casper (c-FLIP) in regulation of death receptor-induced apoptosis and embryonic development. Immunity (2000) 3.29
The pivotal role of tumour necrosis factor alpha in the development of inflammatory hyperalgesia. Br J Pharmacol (1992) 3.21
Interleukin-1 beta as a potent hyperalgesic agent antagonized by a tripeptide analogue. Nature (1988) 2.72
Cytokines, nerve growth factor and inflammatory hyperalgesia: the contribution of tumour necrosis factor alpha. Br J Pharmacol (1997) 2.59
Bacterial modulins: a novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesis. Microbiol Rev (1996) 2.55
A cascade of cytokines mediates mechanical inflammatory hypernociception in mice. Proc Natl Acad Sci U S A (2005) 2.53
Deficiency of T2K leads to apoptotic liver degeneration and impaired NF-kappaB-dependent gene transcription. EMBO J (2000) 2.48
Self-reported physician practices for children with asthma: are national guidelines followed? Pediatrics (2000) 2.31
Decreased bone mineral density in premenopausal asthma patients receiving long-term inhaled steroids. Chest (1994) 2.31
Interleukin 1 in the brain: biology, pathology and therapeutic target. Trends Neurosci (2000) 2.27
Involvement of resident macrophages and mast cells in the writhing nociceptive response induced by zymosan and acetic acid in mice. Eur J Pharmacol (2000) 2.16
Sequence and expression of the discoidin I gene family in Dictyostelium discoideum. J Mol Biol (1981) 2.16
Contribution of interleukin-1 beta to the inflammation-induced increase in nerve growth factor levels and inflammatory hyperalgesia. Br J Pharmacol (1995) 2.12
Identification of a novel gene cluster encoding staphylococcal exotoxin-like proteins: characterization of the prototypic gene and its protein product, SET1. Infect Immun (2000) 2.07
The molecular pharmacology of CGRP and related peptide receptor subtypes. Trends Pharmacol Sci (2000) 2.04
Surgical lateral clearance in resected rectal carcinomas. A multivariate analysis of clinicopathologic features. Cancer (1993) 1.99
Attenuation of the euphoric effects of cocaine by the dopamine D1/D5 antagonist ecopipam (SCH 39166) Arch Gen Psychiatry (1999) 1.94
Experience with vesicoureteral reflux in children: clinical characteristics. J Urol (1997) 1.87
Abnormal immunoreactivity of the E-cadherin-catenin complex in gastric carcinoma: relationship with patient survival. Gastroenterology (1997) 1.86
Effects of a gastrin-like pentapeptide (I.C.I. 50,123) on stomach and pancreas. Lancet (1966) 1.85
A simple sensitive bioassay for interleukin-1 which is unresponsive to 10(3) U/ml of interleukin-2. J Immunol Methods (1987) 1.80
Circulating interleukin-6 mediates the febrile response to localised inflammation in rats. J Physiol (2000) 1.75
Interleukin-8 as a mediator of sympathetic pain. Br J Pharmacol (1991) 1.71
Recombinant interleukin-1 and tumor necrosis factor induce neutrophil migration "in vivo" by indirect mechanisms. Agents Actions (1990) 1.71
Monoclonal antibody TGN1412 trial failure explained by species differences in CD28 expression on CD4+ effector memory T-cells. Br J Pharmacol (2010) 1.65
Analysis of the multigene family coding the developmentally regulated carbohydrate-binding protein discoidin-I in D. discoideum. Cell (1980) 1.60
Cisplatin-based chemotherapy for ovarian germ cell malignancies: the Australian experience. J Clin Oncol (1994) 1.59
TRAF2 deficiency results in hyperactivity of certain TNFR1 signals and impairment of CD40-mediated responses. Immunity (1999) 1.56
Effects of prognosis, perceived benefit, and decision style on decision making and critical care on decision making in critical care. Crit Care Med (1999) 1.46
Cytokine profiles during carrageenan-induced inflammatory hyperalgesia in rat muscle and hind paw. J Pain (2006) 1.45
Bradykinin initiates cytokine-mediated inflammatory hyperalgesia. Br J Pharmacol (1993) 1.44
Scanning electron microscopy of Chilomastix mesnili (Wenyon 1910) Alexieieff, 1912. Parasitol Res (2000) 1.41
Microvessel density, vascular endothelial growth factor and its receptors Flt-1 and Flk-1/KDR in hepatocellular carcinoma. Am J Clin Pathol (2001) 1.39
Behavioral insensitivity to restraint stress, absent fear suppression of behavior and impaired spatial learning in transgenic rats with hippocampal neuropeptide Y overexpression. Proc Natl Acad Sci U S A (2000) 1.38
An initial investigation of spinal mechanisms underlying pain enhancement induced by fractalkine, a neuronally released chemokine. Eur J Neurosci (2005) 1.36
Mycobacterium tuberculosis chaperonin 60.1 is a more potent cytokine stimulator than chaperonin 60.2 (Hsp 65) and contains a CD14-binding domain. Infect Immun (2001) 1.33
Lipopolysaccharide induces sickness behaviour in rats by a vagal mediated mechanism. C R Acad Sci III (1994) 1.33
Effects of inhibition of PDE4 and TNF-alpha on local and remote injuries following ischaemia and reperfusion injury. Br J Pharmacol (2001) 1.30
Interleukin-1 mediates a rapid inflammatory response after injection of adenoviral vectors into the brain. J Neurosci (1999) 1.30
The effect of photodynamic action on two virulence factors of gram-negative bacteria. Photochem Photobiol (2000) 1.30
Peripheral cell types contributing to the hyperalgesic action of nerve growth factor in inflammation. J Neurosci (1996) 1.28
Effectiveness of propranolol for cocaine dependence treatment may depend on cocaine withdrawal symptom severity. Drug Alcohol Depend (2001) 1.27
Homogeneous Escherichia coli chaperonin 60 induces IL-1 beta and IL-6 gene expression in human monocytes by a mechanism independent of protein conformation. J Immunol (1998) 1.27
A mitochondrial DNA variant at position 16189 is associated with type 2 diabetes mellitus in Asians. Diabetologia (2008) 1.24
The vagus nerve mediates behavioural depression, but not fever, in response to peripheral immune signals; a functional anatomical analysis. Eur J Neurosci (2000) 1.23
Prognostic significance of proliferating cell nuclear antigen expression in hepatocellular carcinoma. Cancer (1994) 1.23
Body temperature regulation and thermoneutrality in rats. Q J Exp Physiol Cogn Med Sci (1977) 1.22
Association of interleukin 1B gene polymorphism and gastric cancers in high and low prevalence regions in China. Gut (2003) 1.22
Anti-inflammatory and analgesic effects of the phosphodiesterase 4 inhibitor rolipram in a rat model of arthritis. Eur J Pharmacol (2000) 1.21
Recombinant Actinobacillus actinomycetemcomitans cytolethal distending toxin proteins are required to interact to inhibit human cell cycle progression and to stimulate human leukocyte cytokine synthesis. Infect Immun (2001) 1.21
Hepatic veno-occlusive disease due to toxic alkaloid herbal tea. Lancet (1983) 1.20
Living with a chronic illness: Chinese-Canadian and Euro-Canadian women with diabetes--exploring factors that influence management. Soc Sci Med (1995) 1.20
Influence of cyclophosphamide and other immunosuppressive drugs on immune disorders and neoplasia in NZB/NZW mice. Arthritis Rheum (1975) 1.19
Surface-associated proteins from Staphylococcus aureus demonstrate potent bone resorbing activity. J Bone Miner Res (1995) 1.16
Role of lipocortin-1 in the anti-hyperalgesic actions of dexamethasone. Br J Pharmacol (1997) 1.15
Cytokine-mediated inflammatory hyperalgesia limited by interleukin-1 receptor antagonist. Br J Pharmacol (2000) 1.14
Central administration of rat IL-6 induces HPA activation and fever but not sickness behavior in rats. Am J Physiol (1999) 1.14
Growth failure occurs through a decrease in insulin-like growth factor 1 which is independent of undernutrition in a rat model of colitis. Gut (2000) 1.13
Interleukin 6 production by lipopolysaccharide-stimulated human fibroblasts is potently inhibited by naphthoquinone (vitamin K) compounds. Cytokine (1995) 1.12
Central nervous action of interleukin-1 mediates activation of limbic structures and behavioural depression in response to peripheral administration of bacterial lipopolysaccharide. Eur J Neurosci (2008) 1.12
The relationship between the circulating concentrations of interleukin 6 (IL-6), tumor necrosis factor (TNF) and the acute phase response to elective surgery and accidental injury. Lymphokine Res (1990) 1.10
Resolution rates of low grade vesicoureteral reflux stratified by patient age at presentation. J Urol (1997) 1.10
Assay of pyrogens by interleukin-6 release from monocytic cell lines. J Pharm Pharmacol (1991) 1.10
Fluorescent oligopeptide substrates for kinetic characterization of the specificity of Astacus protease. Biochemistry (1990) 1.09
Brain sites of action of endogenous interleukin-1 in the febrile response to localized inflammation in the rat. J Physiol (1999) 1.09
Evaluation of the semi-automated Autosperm semen analysis system. II. Comparison with conventional method, time-exposure photomicrography, and automated CellSoft system. Fertil Steril (1990) 1.08
p21/WAF1, p53 and PCNA expression and p53 mutation status in hepatocellular carcinoma. Int J Cancer (1998) 1.08
Cytokine degradation by biofilms of Porphyromonas gingivalis. Curr Microbiol (1998) 1.07
Cross-sectional study of semen parameters in a large group of normal Chinese men. Int J Androl (1985) 1.07
Structural domains of the avian erythroblastosis virus erbB protein required for fibroblast transformation: dissection by in-frame insertional mutagenesis. J Virol (1986) 1.07
E-cadherin/catenin complex in benign and malignant melanocytic lesions. J Pathol (1998) 1.06
Corticotrophin-releasing hormone (CRH)-binding protein interference with CRH antibody binding: implications for direct CRH immunoassay. J Endocrinol (1995) 1.06
Interactions between periodontopathogenic bacteria and cytokines. J Periodontal Res (1997) 1.06
Cytokine-mediated inflammatory hyperalgesia limited by interleukin-4. Br J Pharmacol (1999) 1.06
Acute cholangitis--predictive factors for emergency ERCP. Aliment Pharmacol Ther (2001) 1.05
p53 mutation is a poor prognostic indicator for survival in patients with hepatocellular carcinoma undergoing surgical tumour ablation. Br J Cancer (1998) 1.05
Effects of intrahypothalamic injections of noradrenaline and carbachol on core temperature of unrestrained rats [proceedings]. Br J Pharmacol (1977) 1.04
Role of circulating endotoxin and interleukin-6 in the ACTH and corticosterone response to intraperitoneal LPS. Am J Physiol (1997) 1.03
Expression of P-glycoprotein in hepatocellular carcinoma. A determinant of chemotherapy response. Am J Clin Pathol (2000) 1.03
Autoregulation of bradykinin receptors: agonists in the presence of interleukin-1beta shift the repertoire of receptor subtypes from B2 to B1 in human lung fibroblasts. Mol Pharmacol (1999) 1.02
Characterization of CGRP1 and CGRP2 receptor subtypes. Ann N Y Acad Sci (1992) 1.02
Biological activity and brain actions of recombinant rat interleukin-1alpha and interleukin-1beta. Eur Cytokine Netw (1998) 1.01
Use of isolated chromaffin cells to study basic release mechanisms. J Auton Nerv Syst (1983) 1.00
Comparative affinities and antagonistic potencies of various human calcitonin gene-related peptide fragments on calcitonin gene-related peptide receptors in brain and periphery. J Pharmacol Exp Ther (1991) 1.00
Rat interleukin 6: expression in recombinant Escherichia coli, purification and development of a novel ELISA. Cytokine (1999) 0.98
Interleukin-6 is a candidate molecule that transmits inflammatory information to the CNS. Neuroscience (2007) 0.98
Influence of tumor-derived interleukin 1 on melanoma-endothelial cell interactions in vitro. Cancer Res (1991) 0.98
The international standard for interleukin-6. Evaluation in an international collaborative study. J Immunol Methods (1993) 0.98
Modification of basal release of prostaglandins from rabbit isolated hearts. Prostaglandins (1974) 0.98
Interleukin-1 beta production in vivo and in vitro in rats and mice measured using specific immunoradiometric assays. J Mol Endocrinol (1991) 0.97
The role of the sympathetic efferents in endotoxin-induced localized inflammatory hyperalgesia and cytokine upregulation. Neuropharmacology (2002) 0.97
Blockade of the chemokine receptor CXCR2 ameliorates adjuvant-induced arthritis in rats. Br J Pharmacol (2007) 0.97